The combination of B-type natriuretic peptide and C-reactive protein provides incremental prognostic value among older patients referred for cardiac catheterization.

about

Genetic variation in the natriuretic peptide system and heart failure.Bench-to-bedside review: the value of cardiac biomarkers in the intensive care patient.Recent advances and clinical insights into the use of proteomics in the study of atherosclerosis.

P2860

Q35046791-1666FF74-D680-4597-8D3D-B3DF40060391 Q37192660-359E6F8E-D982-479C-AAAA-1C8E891D04FE Q39423557-7D5DB379-B220-4F38-8157-8D6B7B8B6EB7

P2860

The combination of B-type natriuretic peptide and C-reactive protein provides incremental prognostic value among older patients referred for cardiac catheterization.

Item

http://www.wikidata.org/entity/Q48112440

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

The combination of B-type natr ...... d for cardiac catheterization.

@en

The combination of B-type natr ...... d for cardiac catheterization.

@nl

type

Item

label

The combination of B-type natr ...... d for cardiac catheterization.

@en

The combination of B-type natr ...... d for cardiac catheterization.

@nl

prefLabel

The combination of B-type natr ...... d for cardiac catheterization.

@en

The combination of B-type natr ...... d for cardiac catheterization.

@nl

P1476

The combination of B-type natr ...... d for cardiac catheterization.

@en

P2093

Joshua M Stolker

http://www.w3.org/2001/XMLSchema#string

Michael W Rich

http://www.w3.org/2001/XMLSchema#string

P2860

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000.

How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review

Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?

N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arte

Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography.

Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy.

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.

P304

229-235

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1076-7460.2007.05649.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17617749

http://www.w3.org/2001/XMLSchema#string

The combination of B-type natriuretic peptide and C-reactive protein provides incremental prognostic value among older patients referred for cardiac catheterization.

about

P2860

P2860

The combination of B-type natriuretic peptide and C-reactive protein provides incremental prognostic value among older patients referred for cardiac catheterization.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698